Skip to main content

Blackstone Inc.

Position in APGE — Apogee Therapeutics, Inc.

CIK 1393818 NEW YORK, NY

Position in APGE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,604,705
-$2,307,196 QoQ
Shares Held
12,090
-76.7% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#163
of 285 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in APGE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Blackstone Inc. holds $252,665,757 across 52 Biotechnology names. APGE ranks #22 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in APGE

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,604,705 12,090
2025-12-31 $3,911,901 51,827
2025-09-30 $7,562,684 190,352
2025-06-30 $7,754,252 178,546
2025-03-31 $6,864,787 183,747
2024-12-31 $3,624,000 80,000
2024-09-30 $4,699,200 80,000
2024-06-30 $3,148,000 80,000
2024-03-31 $15,283,500 230,000
2023-12-31 $9,829,571 351,810
2023-09-30 $6,371,298 299,122